Company announcements

Dealing in securities by executive directors, prescribed officers and company secretary

October 03, 2025

---

Johannesburg, Friday, 03 October 2025. In line with the provisions of the 2018 Harmony Deferred Share Plan, executive directors and prescribed officers of Harmony were awarded deferred shares on 18 September 2025 based on the 5-day volume weighted average price of R263.44 per ordinary share and accepted these awards on 02 October 2025. In addition, in compliance with paragraphs 3.63 to 3.74 of the JSE Listings Requirements, dealings in securities by executive directors and prescribed officers are disclosed.
The following transactions are disclosed in relation to the deferred share awards:

1.	Name of director:	BB Nel (Group Chief Executive Officer)
	Nature of transaction:	Off market award of deferred shares
	Periods of vesting:	Deferred shares vest in five equal tranches over a five-year period
	Class of securities:	Deferred ordinary shares
	Number of deferred shares awarded:	65 406
	Total value of shares awarded:	R17 230 556.64
	Nature and extent of director’s interest:	Direct beneficial
2.	Name of director:	BP Lekubo (Financial Director)
	Nature of transaction:	Off market award of deferred shares
	Periods of vesting:	Deferred shares vest in five equal tranches over a five-year period
	Class of securities:	Deferred ordinary shares
	Number of deferred shares awarded:	40 148
	Total value of shares awarded:	R10 576 589.12
	Nature and extent of director’s interest:	Direct beneficial
3.	Name of director:	HE Mashego (Executive Director)
	Nature of transaction:	Off market award of deferred shares
	Periods of vesting:	Deferred shares vest in five equal tranches over a five-year period
	Class of securities:	Deferred ordinary shares
	Number of deferred shares awarded:	29 845
	Total value of shares awarded:	R7 862 366.80
	Nature and extent of director’s interest:	Direct beneficial
4.	Name of prescribed officer:	AJ Boshoff
	Nature of transaction:	Off market award of deferred shares
	Periods of vesting:	Deferred shares vest in five equal tranches over a five-year period
	Class of securities:	Deferred ordinary shares
	Number of deferred shares awarded:	33 646
	Total value of shares awarded:	R8 863 702.24
	Nature and extent of prescribed officer’s interest:	Direct beneficial
5.	Name of prescribed officer:	AZ Buthelezi
	Nature of transaction:	Off market award of deferred shares
	Periods of vesting:	Deferred shares vest in five equal tranches over a five-year period
	Class of securities:	Deferred ordinary shares
	Number of deferred shares awarded:	28 090
	Total value of shares awarded:	R7 400 029.60
	Nature and extent of prescribed officer’s interest:	Direct beneficial
6.	Name of prescribed officer:	U Govender
	Nature of transaction:	Off market award of deferred shares
	Periods of vesting:	Deferred shares vest in five equal tranches over a five-year period
	Class of securities:	Deferred ordinary shares
	Number of deferred shares awarded:	20 394
	Total value of shares awarded:	R5 372 595.36
	Nature and extent of prescribed officer’s interest:	Direct beneficial
7.	Name of prescribed officer:	FS Masemula
	Nature of transaction:	Off market award of deferred shares
	Periods of vesting:	Deferred shares vest in five equal tranches over a five-year period
	Class of securities:	Deferred ordinary shares
	Number of deferred shares awarded:	27 358
	Total value of shares awarded:	R7 207 191.52
	Nature and extent of prescribed officer’s interest:	Direct beneficial
8.	Name of prescribed officer:	JJ van Heerden
	Nature of transaction:	Off market award of deferred shares
	Periods of vesting:	Deferred shares vest in five equal tranches over a five-year period
	Class of securities:	Deferred ordinary shares
	Number of deferred shares awarded:	39 337
	Total value of shares awarded:	R10 362 939.28
	Nature and extent of prescribed officer’s interest:	Direct beneficial
9.	Name of prescribed officer:	MP van der Walt
	Nature of transaction:	Off market award of deferred shares
	Periods of vesting:	Deferred shares vest in five equal tranches over a five-year period
	Class of securities:	Deferred ordinary shares
	Number of deferred shares awarded:	28 090
	Total value of shares awarded:	R7 400 029.60
	Nature and extent of prescribed officer’s interest:	Direct beneficial
10.	Name of company secretary:	SS Mohatla
	Nature of transaction:	Off market award of deferred shares
	Periods of vesting:	Deferred shares vest in three equal tranches over a three-year period
	Class of securities:	Deferred ordinary shares
	Number of deferred shares awarded:	13 994
	Total value of shares awarded:	R3 686 579.36
	Nature and extent of company secretary’s interest:	Direct beneficial

Prior clearance was obtained in respect of the above dealings by the executive directors, prescribed officers and company secretary.

Ends.

For more details contact:

Jared Coetzer
Head of Investor Relations
+27 (0) 82 746 4120
Johannesburg, South Africa

03 October 2025

Sponsor: J.P. Morgan Equities South Africa Proprietary Limited